Meeting
2012 Gastrointestinal Cancers Symposium
DPD deficiency: Medicoeconomic evaluation of pretreatment screening of 5-FU toxicity.
Authors
Sory Traoré
Centre Paul Papin, CRNA INSERM 892, Angers, France
Sory Traoré , Michele Boisdron-Celle , Gilles Hunault , Thierry Andre , Alain Morel , Veronique Guerin-Meyer , Olivier Capitain , Erick Gamelin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 410)
DOI
10.1200/jco.2012.30.4_suppl.410
Abstract #
410
Poster Bd #
A29
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Pre-therapeutic dihydropyridimidine dehydrogenase (DPD) deficiency screening: Impact on fluoropyrimidine dose reduction at the second chemotherapy cycle and on early severe toxicity.
First Author: Côme De Metz
Poster
2013 ASCO Annual Meeting
Prevention of 5-FU-induced health-threatening toxicity by pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.
First Author: Michele Boisdron-Celle
Poster
2013 Gastrointestinal Cancers Symposium
Prevention of 5-FU-induced toxicities using pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.
First Author: Michele Boisdron-Celle
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of plasma uracil concentration with 5-FU pharmacokinetics, dose-limiting toxicity, and DPYD genotype in patients with gastrointestinal cancer.
First Author: Gabriel A. Brooks